Immune System-Related Changes in Preclinical GL261 Glioblastoma under TMZ Treatment: Explaining MRSI-Based Nosological Imaging Findings with RT-PCR Analyses

Immune System-Related Changes in Preclinical GL261 Glioblastoma under TMZ Treatment: Explaining MRSI-Based Nosological Imaging Findings with RT-PCR Analyses

Glioblastomas (GB) are brain tumours with poor prognosis even after aggressive therapy. Previous work suggests that magnetic resonance spectroscopic imaging (MRSI) could act as a biomarker of efficient immune system attack onto GB, presenting oscillatory changes. Glioma-associated microglia/macropha...

Full description

Bibliographic Details
Main Authors:	Pilar Calero-Pérez, Shuang Wu, Carles Arús, Ana Paula Candiota
Format:	Article
Language:	English
Published:	MDPI AG 2021-05-01
Series:	Cancers
Subjects:	glioblastoma orthotopic immunocompetent tumours immune-enhancing metronomic schedule TMZ magnetic resonance spectroscopic imaging immune system activity imaging biomarker
Online Access:	https://www.mdpi.com/2072-6694/13/11/2663

Similar Items

Anti-PD-1 Immunotherapy in Preclinical GL261 Glioblastoma: Influence of Therapeutic Parameters and Non-Invasive Response Biomarker Assessment with MRSI-Based Approaches
by: Shuang Wu, et al.
Published: (2020-11-01)

Metabolomics of Therapy Response in Preclinical Glioblastoma: A Multi-Slice MRSI-Based Volumetric Analysis for Noninvasive Assessment of Temozolomide Treatment
by: Nuria Arias-Ramos, et al.
Published: (2017-05-01)

Successful Partnerships: Exploring the Potential of Immunogenic Signals Triggered by TMZ, CX-4945, and Combined Treatment in GL261 Glioblastoma Cells
by: Lucía Villamañan, et al.
Published: (2021-03-01)

Metronomic Temozolomide (mTMZ) and Bevacizumab—The Safe and Effective Frontier for Treating Metastatic Neuroendocrine Tumors (NETs): A Single-Center Experience
by: Çağlar Ünal, et al.
Published: (2023-12-01)

Targeting Protein Kinase CK2: Evaluating CX-4945 Potential for GL261 Glioblastoma Therapy in Immunocompetent Mice
by: Laura Ferrer-Font, et al.
Published: (2017-02-01)

Correlation of MR-Based Metabolomics and Molecular Profiling in the Tumor Microenvironment of Temozolomide-Treated Orthotopic GL261 Glioblastoma in Mice
by: Kai Zhao, et al.
Published: (2023-12-01)

Establishing Imaging Biomarkers of Host Immune System Efficacy during Glioblastoma Therapy Response: Challenges, Obstacles and Future Perspectives
by: Ana Paula Candiota, et al.
Published: (2022-03-01)

Investigating the Stability of Six Phenolic TMZ Ester Analogues, Incubated in the Presence of Porcine Liver Esterase and Monitored by HPLC
by: Leroy A. Shervington, et al.
Published: (2022-05-01)

Downfield Proton MRSI at 3 Tesla: A Pilot Study in Human Brain Tumors
by: İpek Özdemir, et al.
Published: (2023-08-01)

Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1–Survivin axis
by: Jun-Hai Tang, et al.
Published: (2019-12-01)

Improving the Effective Spatial Resolution in <sup>1</sup>H-MRSI of the Prostate with Three-Dimensional Overdiscretized Reconstructions
by: Carlijn J. A. Tenbergen, et al.
Published: (2023-01-01)

Development of a Mouse Glioblastoma Orthotopic Model Using the GLi-261 Cell Line
by: A. A. Borzov, et al.
Published: (2019-12-01)

miR-1297 sensitizes glioma cells to temozolomide (TMZ) treatment through targeting adrenomedullin (ADM)
by: Zongze He, et al.
Published: (2022-10-01)

Metronomic Chemotherapy: Anti-Tumor Pathways and Combination with Immune Checkpoint Inhibitors
by: Elena Muraro, et al.
Published: (2023-04-01)

A Novel Approach for Glioblastoma Treatment by Combining Apoptosis Inducers (TMZ, MTX, and Cytarabine) with E.V.A. (Eltanexor, Venetoclax, and A1210477) Inhibiting XPO1, Bcl-2, and Mcl-1
by: Kai Zhao, et al.
Published: (2024-04-01)

High-resolution metabolic imaging of high-grade gliomas using 7T-CRT-FID-MRSI
by: Gilbert Hangel, et al.
Published: (2020-01-01)

Role of Metformin and AKT Axis Modulation in the Reversion of Hypoxia Induced TMZ-Resistance in Glioma Cells
by: Alessia Lo Dico, et al.
Published: (2019-05-01)

Identification of miRNA signature associated with BMP2 and chemosensitivity of TMZ in glioblastoma stem-like cells
by: Xiaoyu Guo, et al.
Published: (2020-09-01)

Experimental study of selective MGMT peptides mimicking TMZ drug resistance in glioma
by: Yue Wu, et al.
Published: (2022-12-01)

Intravoxel Incoherent Motion Diffusion-Weighted MR Imaging for Monitoring the Immune Response of Immunogenic Chemotherapy
by: Junjiao Hu, et al.
Published: (2022-05-01)

Identification of the E2F1-RAD51AP1 axis as a key factor in MGMT-methylated GBM TMZ resistance
by: Junhu Zhou, et al.
Published: (2023-05-01)

Compartment-based reconstruction of acquisition-weighted 31P cardiac MRSI reduces sensitivity to cardiac motion and scan planning
by: Andrew Tyler, et al.
Published: (2024-01-01)

BMX, a specific HDAC8 inhibitor, with TMZ for advanced CRC therapy: a novel synergic effect to elicit p53-, β-catenin- and MGMT-dependent apoptotic cell death
by: Huey-Jiun Ko, et al.
Published: (2022-12-01)

Metronomic Chemotherapy for Metastatic Breast Cancer Treatment: Clinical and Preclinical Data between Lights and Shadows
by: Marina Elena Cazzaniga, et al.
Published: (2022-08-01)

Intravital Imaging of Adoptive T-Cell Morphology, Mobility and Trafficking Following Immune Checkpoint Inhibition in a Mouse Melanoma Model
by: Doreen Lau, et al.
Published: (2020-07-01)

Immune challenge affects reproductive behaviour in the guppy (Poecilia reticulata)
by: Stella A. Encel, et al.
Published: (2023-08-01)

Development of a Proton-Frequency-Transparent Birdcage Radiofrequency Coil for In Vivo <sup>13</sup>C MRS/MRSI Study in a 3.0 T MRI System
by: Jun-Sik Yoon, et al.
Published: (2021-12-01)

Delicate Balances in Cancer Chemotherapy: Modeling Immune Recruitment and Emergence of Systemic Drug Resistance
by: Anh Phong Tran, et al.
Published: (2020-06-01)

Immunobiological aspects of cow lactation
by: M. M. Zhelavskyi
Published: (2019-11-01)

Non-Invasive Imaging and Scoring of Peritoneal Metastases in Small Preclinical Animal Models Using Ultrasound: A Preliminary Trial
by: Roxan F. C. P. A. Helderman, et al.
Published: (2022-07-01)

Outcomes of advanced epithelial ovarian cancer with integration of metronomic chemotherapy: An Indian rural cancer centre experience
by: Avinash Pandey, et al.
Published: (2016-01-01)

Oral etoposide and cyclophosphamide: A low-cost palliative metronomic chemotherapy in advanced pediatric cancers
by: Kiran Kumar, et al.
Published: (2020-01-01)

Colon-specific immune microenvironment regulates cancer progression versus rejection
by: Giulia Trimaglio, et al.
Published: (2020-01-01)

Accurately Controlled Delivery of Temozolomide by Biocompatible UiO-66-NH2 Through Ultrasound to Enhance the Antitumor Efficacy and Attenuate the Toxicity for Treatment of Malignant Glioma
by: Wan Z, et al.
Published: (2021-10-01)

Integral Field Spectroscopic Data Reduction Method for High Resolution Infrared Observation
by: Sungho Lee, et al.
Published: (2010-12-01)

Translational Learnings in the Development of Chemo-Immunotherapy Combination to Bypass the Cold Tumor Microenvironment in Pancreatic Ductal Adenocarcinoma
by: Hélène Kaplon
Published: (2022-05-01)

Translational multimodality optical imaging /
by: Azar, Fred S, et al.
Published: (2008)

Translational multimodality optical imaging [electronic resource] /
by: Azar, Fred S, et al.
Published: (2008)

Hyperspectral data processing : algorithm design and analysis /
by: Chang, Chein-I., et al.
Published: (c201)

Live-cell calcium imaging of adherent and non-adherent GL261 cells reveals phenotype-dependent differences in drug responses
by: Averey D. Strong, et al.
Published: (2017-08-01)